Clinical Trials Browser

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

Clinical Trials

FAPI

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

DIDO

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

UNITO-001

MiST

Immunological Variables Associated to ICI Toxicity in Cancer Patients

A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations

A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of Patients

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation

Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)

A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor

Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients

PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer

A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma

Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation

Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases

Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor

The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Pegteograstim in Children With Solid Tumors

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation

ADAM

A Study: Pure CBD as Single-agent for Solid Tumor.

Efficacy Study of Lucentis in the Treatment of Retinoblastoma

cat´sclaw

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

Oxaliplatin for Children With Solid Tumors

SKOPOS

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

AGILI

SMS